BETHESDA, Md.--(BUSINESS WIRE)--Micromet, Inc. (Nasdaq:MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, announced today that the Company will participate in the 2010 Newsmakers in the Biotechnology Industry Conference, to be held on October 22, 2010 in New York City. Christian Itin, Ph.D., the Company’s President and CEO, will present a 25 minute corporate overview at 2:30 PM ET.
